左炔诺孕酮宫内缓释系统对子宫腺肌症患者月经及卵巢功能的影响研究
2016-03-10黄茂兰肖雁冰
涂 皎,高 毅,黄茂兰,肖雁冰
·论著·
左炔诺孕酮宫内缓释系统对子宫腺肌症患者月经及卵巢功能的影响研究
涂 皎,高 毅,黄茂兰,肖雁冰
E-mail:xiaoyb7683@163.com
【摘要】目的探讨左炔诺孕酮宫内缓释系统对子宫腺肌症患者月经及卵巢功能的影响。方法选取2011年8月—2014年2月在遵义市妇幼保健院接受治疗的子宫腺肌症患者180例。采用随机抽签法,将患者分为对照组和观察组各90例。对照组口服米非司酮治疗,观察组采用宫内放置左炔诺孕酮宫内缓释系统治疗,治疗时间均为3个月。记录并比较两组治疗前后的月经情况和卵巢功能,以及两组用药期间的不良反应发生情况。结果两组平均年龄、平均病程、子宫体积及子宫内膜厚度比较,差异无统计学意义(P>0.05)。治疗前两组月经期、月经周期及痛经程度评分比较,差异无统计学意义(P>0.05)。治疗后两组月经期及月经周期比较,差异无统计学意义(P>0.05);而痛经程度评分比较,差异有统计学意义(P<0.05)。治疗后,两组月经期、月经周期及痛经程度评分与治疗前比较,差异均有统计学意义(P<0.05)。治疗前、后,两组血清卵泡刺激素(FSH)和黄体生成素(LH)水平比较,差异均无统计学意义(P>0.05);治疗后,两组血清FSH和LH水平与治疗前比较,差异亦无统计学意义(P>0.05)。治疗期间,两组不良反应发生率比较,差异无统计学意义(P>0.05)。结论左炔诺孕酮宫内缓释系统可以改善子宫腺肌症患者的月经情况,减轻其痛经程度,对卵巢功能影响较小,安全性较高,值得在临床上推广应用。
【关键词】子宫疾病;左炔诺孕酮宫内缓释系统;月经;卵巢功能
涂皎,高毅,黄茂兰,等.左炔诺孕酮宫内缓释系统对子宫腺肌症患者月经及卵巢功能的影响研究[J].中国全科医学,2016,19(4):427-430.[www.chinagp.net]
Tu J,Gao Y,Huang ML,et al.Influence of levonorgestrel-releasing intrauterine system on menstruation and ovarian function of patients with adenomyosis of uterus[J].Chinese General Practice,2016,19(4):427-430.
Influence of Levonorgestrel-releasing Intrauterine System on Menstruation and Ovarian Function of Patients With Adenomyosis of UterusTUJiao,GAOYi,HUANGMao-lan,etal.DepartmentofGynecology,theAffiliatedMaternalandChildrenHospitalofZunyiMedicalCollege,Zunyi563000,China
【Abstract】ObjectiveTo investigate the influence of levonorgestrel-releasing intrauterine system on menstruation and ovarian function of patients with adenomyosis of uterus.MethodsWe enrolled 180 patients with adenomyosis of uterus who were treated from August 2011 to February 2014.Using random sampling method,we divided the patients into control group and observation group,with 90 patients in each group.The control group was orally administrated with mifepristone,and the observation group was treated with levonorgestrel-releasing intrauterine system implanted in uterus.The treatment all lasted for 3 months.Menstruation and ovarian function were recorded and compared between the two groups before and after treatment,and the adverse reactions during treatment were also recorded.ResultsThe two groups were not significantly different in average age,average length of disease,volume of uterus and thickness of endometrium(P>0.05).Before treatment,the two groups were not significantly different in menstrual period,menstrual cycle and dysmenorrheal degree(P>0.05).After treatment,the two groups were not significantly different in menstrual period and menstrual cycle(P>0.05);the two groups were significantly different in dysmenorrhea degree (P<0.05).Before and after treatment,the two groups were not significantly in serum FSH and LH level(P>0.05);serum FSH and LH levels of the two groups after treatment were not significantly different from those before treatment(P>0.05).During treatment,the two groups were not significantly different in adverse reaction rate(P>0.05).ConclusionLevonorgestrel-releasing intrauterine system can improve menstruation and relieve dysmenorrhea.It has only few influence on ovarian function and is safe,worth to be promoted in clinical practice.
【Key words】Uterine diseases;Levonorgestrel-releasing intrauterine system;Menstruation;Ovarian function
子宫腺肌症(adenomyosis,AM)是育龄期妇女常见病,也是较为常见的雌激素依赖性疾病,多发于30~50岁经产妇[1],主要临床表现为继发性痛经、月经量过多、不孕等[2]。近年来,我国的子宫腺……
